The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States

Canadian Journal of Cardiology

Volumn 29, Issue 5, 2013, Pages 598-605

  McAlister, Finlay A ^a   Robitaille, Cynthia ^b   Gillespie, Cathleen ^c   Yuan, Keming ^c   Rao, Deepa P ^b   Grover, Steven ^d   Dai, Sulan ^b   Johansen, Helen ^e   Joffres, Michel ^f   Loustalot, Fleetwood ^c   Campbell, Norm ^g  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f SIMON FRASER UNIVERSITY   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CANADA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FRAMINGHAM RISK SCORE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; SMOKING; UNITED STATES;

ADULT; ATHEROSCLEROSIS; BLOOD PRESSURE; CANADA; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 84876815780     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.12.004     Document Type: Article

References (35)

1. McAlister F.A., Campbell N.R.C., Zarnke K., Levine M., Graham I. The management of hypertension in Canada: a review of current guidelines, their shortcomings, and implications for the future. CMAJ 2001, 164:517-522.
2. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
3. O'Donnell M.J., Zavier D., Liu L., Zhang H., Chin S.L., Rao-Melacini P. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
4. MacMahon S., Neal B., Rodgers A. Hypertension-time to move on. Lancet 2005, 365:1108-1109.
5. Yang Q., Cogswell M.E., Flanders W.D., et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 2012, 307:1273-1283.
6. Kahn R., Robertson R.M., Smith R., Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Circulation 2008, 118:576-585.
7. Tomaselli G.F., Harty M.B., Horton K., Schoeberl M. The American Heart Association and the Million Hearts Initiative: a presidential advisory from the American Heart Association. Circulation 2011, 124:1795-1799.
8. Turner B.J., Hollenbeak C.S., Weiner M., Have T.T., Tang S.S. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med 2008, 148:578-586.
9. Petersen L.A., Woodard L.D., Henderson L.M., Urech T.H., Pietz K. Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients?. Circulation 2009, 119:2978-2985.
10. Wilkins K., Campbell N.R.C., Joffres M.R., et al. Blood pressure in Canadian adults. Health Reports 2010, 21:37-46.
11. Centers for Disease Control and Prevension. National Health and Nutrition Examination survey data. Hyattsville, MD: US Department of Health and Human Services, CDC; 2010. Available at:. Accessed December 2, 2011. http://www.cdc.gov/nchs/nhanes.htm.
12. McAlister F.A., Wilkins K.M., Joffres M., et al. Changes in hypertension awareness, treatment, and control rates in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
13. Myers M.G., McInnis N.H., Fodor G.J., et al. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens 2008, 21:280-283.
14. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
15. World Health Organization (WHO) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of the WHO/IDF Consultation 2006, WHO Press, Geneva, Switzerland, 1-46.
16. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
17. Bhatt D.L., Steg P.G., Ohman E.M., REACH Registry Investigators, et al. International prevalence, recognition, and treatment for cardiovascular risk factor in outpatients with atherothrombosis. JAMA 2006, 295:180-189.
18. MacDonald S., Joffres M.R., Stachenko S., Horlick L., Fodor G. Multiple cardiovascular disease risk factors in Canadian adults. CMAJ 1992, 146:2021-2029.
19. McAlister F.A., Teo K.K., Lewanczuk R.Z., Wells G., Montague T.J. Contemporary practice patterns in the management of newly diagnosed hypertension. Can Med Assoc J 1997, 157:23-30.
20. Stamler J., Stamler R., Neaton J.D., et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999, 282:2012-2018.
21. Petrella R.J., Merikle E. A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada. Clin Ther 2008, 30:1145-1154.
22. Thoenes M., Neuberger H.R., Volpe M., Khan B.V., Kirch W., Bohm M. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens 2010, 24:336-344.
23. Belletti D., Zacker C., Wogen J. Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States. Cardiovasc Diabetology 2010, 9:7-11.
24. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010, 303:2043-2050.
25. Lindholm L., Ejlertsson G., Schersten B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives: a retrospective study of 40-59 year old hypertensives in a Swedish primary care district. Acta Med Scand 1984, 216:251-259.
26. Andersson O.K., Almgren T., Persson B., Samuelsson O., Hedner T., Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ 1998, 317:167-171.
27. Gudmundsson L.S., Johannsson M., Thorgeirsson G., et al. Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykavik Study. J Hum Hypertension 2004, 18:615-622.
28. Gu Q., Burt V.L., Paulose-Ram R., Yoon S., Gillum R.F. High blood pressure and cardiovascular disease mortality risk among US adults: The Third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol 2008, 18:302-309.
29. Benetos A., Thomas F., Bean K.E., Guize L. Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens 2003, 21:1635-1640.
30. Lee D.S., Chiu M., Manuel D.G., et al. Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ 2009, 181:e55-e66.
31. Tsuyuki R.T., McLean D.L., McAlister F.A. Management of hypertension in elderly long-term-care residents. Can J Cardiol 2008, 24:912-915.
32. Berger J.S., Jordan C.O., Lloyd-Jones D., Blumenthal R.S. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2010, 55:1169-1177.
33. Shay C.M., Ning H., Allen N.B., et al. Status of cardiovascular health in US adults: Prevalence estimates from the National Health and Nutrition Examination Survey (NHANES) 2003-2008. Circulation 2012, 125:45-56.
34. Bambs C., Kip K.E., Dinga A., Mulukutla S.R., Aiyer A.N., Reis S.E. Low prevalence of "ideal cardiovascular health" in a community-based population: the Heart Strategies Concentrating on Risk Evaluation (Heart Score) study. Circulation 2011, 123:850-857.
35. Daskalopoulou S.S., et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2012, 28:270-287.